Undifferentiated recurrent fevers in pediatrics are clinically distinct from PFAPA syndrome but retain an IL-1 signature.


Journal

Clinical immunology (Orlando, Fla.)
ISSN: 1521-7035
Titre abrégé: Clin Immunol
Pays: United States
ID NLM: 100883537

Informations de publication

Date de publication:
05 2021
Historique:
received: 01 08 2020
revised: 20 02 2021
accepted: 20 02 2021
pubmed: 27 2 2021
medline: 25 6 2021
entrez: 26 2 2021
Statut: ppublish

Résumé

Autoinflammatory disorders of the innate immune system present with recurrent episodes of inflammation often beginning in early childhood. While there are now more than 30 genetically-defined hereditary fever disorders, many patients lack a clear diagnosis. Many pediatric patients are often grouped with patients with periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome despite failing to meet diagnostic criteria. Here, we categorize these patients as syndrome of undifferentiated recurrent fever (SURF), and identify the unique features which distinguish them from the PFAPA syndrome. SURF patients were more likely to report gastrointestinal symptoms of nausea, vomiting and abdominal pain, and experienced inconsistent responses to on-demand steroid therapy compared to PFAPA patients. For this previously undefined cohort, an optimal course of therapy remains uncertain, with medical and surgical therapies largely driven by parental preference. A subset of patients with SURF underwent tonsillectomy with complete resolution. Flow cytometric evaluation demonstrates leukocytic populations distinct from PFAPA patients, with reduced CD3+ T cell numbers. SURF patient tonsils were predominantly characterized by an IL-1 signature compared to PFAPA, even during the afebrile period. Peripheral blood signatures were similar between groups suggesting that PFAPA and SURF patient tonsils have localized, persistent inflammation, without clinical symptoms. These data suggest that SURF is a heterogenous syndrome on the autoinflammatory disease spectrum.

Identifiants

pubmed: 33636366
pii: S1521-6616(21)00034-6
doi: 10.1016/j.clim.2021.108697
pmc: PMC8089050
mid: NIHMS1677092
pii:
doi:

Substances chimiques

CD3 Complex 0
Interleukin-1 0

Types de publication

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

108697

Subventions

Organisme : NICHD NIH HHS
ID : K08 HD075830
Pays : United States

Informations de copyright

Copyright © 2021 Elsevier Inc. All rights reserved.

Références

J Pediatr. 2007 Sep;151(3):289-92
pubmed: 17719940
Nat Genet. 1999 Jun;22(2):175-7
pubmed: 10369261
Arthritis Rheum. 2002 Dec;46(12):3340-8
pubmed: 12483741
BMC Ear Nose Throat Disord. 2018 Feb 22;18:3
pubmed: 29483843
Am J Hum Genet. 2002 Jun;70(6):1498-506
pubmed: 11992256
J Clin Immunol. 2020 Jan;40(1):179-190
pubmed: 31807979
Nat Immunol. 2017 Jul 19;18(8):832-842
pubmed: 28722725
Pediatr Int. 2017 Jun;59(6):655-660
pubmed: 28207965
Semin Arthritis Rheum. 2016 Feb;45(4):471-4
pubmed: 26315860
Curr Allergy Asthma Rep. 2016 Jan;16(1):2
pubmed: 26707379
Arthritis Rheumatol. 2017 Nov;69(11):2233-2240
pubmed: 28692792
Eur J Clin Microbiol Infect Dis. 2016 Jun;35(6):963-70
pubmed: 27025724
Ann Rheum Dis. 2006 Nov;65(11):1427-32
pubmed: 16707534
J Pediatr. 2016 Dec;179:172-177.e1
pubmed: 27692464
Ann Rheum Dis. 2019 Oct;78(10):1405-1411
pubmed: 31278138
Cell. 1997 Aug 22;90(4):797-807
pubmed: 9288758
Pediatr Rheumatol Online J. 2020 Apr 15;18(1):31
pubmed: 32293478
Rheumatology (Oxford). 2019 Nov 1;58(Suppl 6):vi44-vi55
pubmed: 31769854
Nat Genet. 1999 Jun;22(2):178-81
pubmed: 10369262
Proc Natl Acad Sci U S A. 2011 Apr 26;108(17):7148-53
pubmed: 21478439
Ann Rheum Dis. 2019 Aug;78(8):1025-1032
pubmed: 31018962
J Pediatr. 2018 Feb;193:265-274.e3
pubmed: 29246466
Nat Genet. 2001 Nov;29(3):301-5
pubmed: 11687797
Mol Immunol. 2015 May;65(1):139-47
pubmed: 25656804
Arch Dis Child. 2006 Dec;91(12):981-4
pubmed: 16595648
J Pediatr. 2018 Jan;192:253-255
pubmed: 29031862
Rheumatology (Oxford). 2014 Jun;53(6):1125-9
pubmed: 24505122
Cell. 1999 Apr 2;97(1):133-44
pubmed: 10199409
Rheumatol Int. 2021 Jan;41(1):183-188
pubmed: 31324971
Proc Natl Acad Sci U S A. 2020 Jun 23;117(25):14405-14411
pubmed: 32518111
Annu Rev Immunol. 2015;33:823-74
pubmed: 25706096
J Pediatr. 1999 Jul;135(1):15-21
pubmed: 10393598
Nat Rev Rheumatol. 2015 Oct;11(10):573-85
pubmed: 26077920

Auteurs

Irene Luu (I)

Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, University of California-San Diego, La Jolla, CA, United States of America.

Javan Nation (J)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Nathan Page (N)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Daniela Carvalho (D)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Anthony Magit (A)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Wen Jiang (W)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Shelby Leuin (S)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Morgan Bliss (M)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Marcella Bothwell (M)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Matthew Brigger (M)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Donald Kearns (D)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Seth Pransky (S)

Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America; Department of Surgery, Division of Otolaryngology, University of California San Diego, La Jolla, CA, United States of America.

Lori Broderick (L)

Department of Pediatrics, Division of Allergy, Immunology and Rheumatology, University of California-San Diego, La Jolla, CA, United States of America; Rady Children's Foundation, Rady Children's Hospital, San Diego, CA, United States of America. Electronic address: lbroderick@ucsd.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH